AAAAAA
Results:
1-8
|
Results: 8
Authors:
Boger, DL
Searcey, M
Tse, WC
Jin, Q
Citation: Dl. Boger et al., Bifunctional alkylating agents derived from duocarmycin SA: Potent antitumor activity with altered sequence selectivity, BIOORG MED, 10(5), 2000, pp. 495-498
Authors:
Boger, DL
Aquila, BM
Tse, WC
Searcey, M
Citation: Dl. Boger et al., Synthesis and evaluation of a novel bleomycin A(2) analogue: continuing assessment of the linker domain, TETRAHEDR L, 41(49), 2000, pp. 9493-9498
Authors:
Boger, DL
Santillan, A
Searcey, M
Brunette, SR
Wolkenberg, SE
Hedrick, MP
Jin, Q
Citation: Dl. Boger et al., Synthesis and evaluation of 1,2,8,8a-tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: Impact of the alkylation subunit substituents and its implications forDNA alkylation catalysis, J ORG CHEM, 65(13), 2000, pp. 4101-4111
Authors:
McClean, S
Costelloe, C
Denny, WA
Searcey, M
Wakelin, LPG
Citation: S. Mcclean et al., Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards, ANTI-CAN DR, 14(3), 1999, pp. 187-204
Authors:
Boger, DL
Boyce, CW
Garbaccio, RM
Searcey, M
Jin, Q
Citation: Dl. Boger et al., CBI prodrug analogs of CC-1065 and the duocarmycins, SYNTHESIS-S, 1999, pp. 1505-1509
Authors:
Boger, DL
Santillan, A
Searcey, M
Jin, Q
Citation: Dl. Boger et al., Synthesis and evaluation of duocarmycin and CC-1065 analogues containing modifications in the subunit linking amide, J ORG CHEM, 64(14), 1999, pp. 5241-5244
Authors:
Boger, DL
Ledeboer, MW
Kume, M
Searcey, M
Jin, Q
Citation: Dl. Boger et al., Total synthesis and comparative evaluation of luzopeptin A-C and quinoxapeptin A-C, J AM CHEM S, 121(49), 1999, pp. 11375-11383
Authors:
Searcey, M
McClean, S
Madden, B
McGown, AT
Wakelin, LPG
Citation: M. Searcey et al., Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivatives, ANTI-CAN DR, 13(8), 1998, pp. 837-855
Risultati:
1-8
|